BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-316@pharmaconomics
DTSTAMP:20260707T030604Z
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260603
SUMMARY:CING CRL — CTx-1301
DESCRIPTION:An FDA complete response letter on CTx-1301 for Attention Deficit/Hyperactivity Disorder (ADHD) is in focus around Jun 2\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1862150/000149315226026760/form8-k.htm\n\nTrack it: https://pharmaconomics.com/e/316
URL:https://pharmaconomics.com/e/316
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CING catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR